日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study

术前放化疗对局部晚期食管胃交界处腺癌患者预后的影响——一项初步研究

Orditura, M; Galizia, G; Di Martino, N; Ancona, E; Castoro, C; Pacelli, R; Morgillo, F; Rossetti, S; Gambardella, V; Farella, A; Laterza, M M; Ruol, A; Fabozzi, A; Napolitano, V; Iovino, F; Lieto, E; Fei, L; Conzo, G; Ciardiello, F; De Vita, F

A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer.

一项多中心 II 期研究,旨在评估 FOLFOX-4 和西妥昔单抗诱导化疗后,再进行放射治疗和西妥昔单抗治疗局部晚期食管癌的疗效

De Vita F, Orditura M, Martinelli E, Vecchione L, Innocenti R, Sileni V C, Pinto C, Di Maio M, Farella A, Troiani T, Morgillo F, Napolitano V, Ancona E, Di Martino N, Ruol A, Galizia G, Del Genio A, Ciardiello F

Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer

局部晚期食管癌的II期临床试验:多西他赛、顺铂和氟尿嘧啶化疗后序贯卡铂化疗和放疗

Chiarion-Sileni, V; Corti, L; Ruol, A; Innocente, R; Boso, C; Del Bianco, P; Pigozzo, J; Mazzarotto, R; Tomassi, O; Ancona, E

p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma

食管鳞状细胞癌中p16/CDKN2改变和pRb表达

Busatto, G; Shiao, Y H; Parenti, A R; Baffa, R; Ruol, A; Plebani, M; Rugge, M

First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up

一线化疗可提高局部晚期(T4,任何N,M0)胸段食管鳞状细胞癌的切除率和长期生存率:163例连续患者5年随访的最终报告

Ancona, E; Ruol, A; Castoro, C; Chiarion-Sileni, V; Merigliano, S; Santi, S; Bonavina, L; Peracchia, A

Serum levels of soluble CD30 in chronic hepatitis B virus infection

慢性乙型肝炎病毒感染患者血清中可溶性CD30水平

Fattovich, G; Vinante, F; Giustina, G; Morosato, L; Alberti, A; Ruol, A; Pizzolo, G